The Chemical Engineer Enhanced Product Development Through Experimental Design

Optimisation of the development cycle for new products is a challenge in the chemical industry. Steel, which in many ways is analogous to chemicals, is produced using a long chain of interdependent process steps. Consequently, large volumes of experiments are required to fully explore process parameter relations. This is more critical for new, highly differentiated products for which understanding of the underlying physical principles is incomplete and thus a-priori exclusion of factors not possible. In this context, the use of statistical Design of Experiments (DOE) to shorten development timescale, maximize the output of experimental capacity and minimize material consumption is essential.
Watch Now

Spotlight

OTHER ON-DEMAND WEBINARS

BEST PRACTICES FOR MANAGING CHEMICAL COMPLIANCE AND PRODUCT STEWARDSHIP

verdantix

Over the past decade, firms of all sizes from global conglomerates to regional manufacturers have faced a plethora of product stewardship challenges, including adapting to changing regulations, minimizing costly product recalls and protecting brand reputation from undesirable social and environmental sourcing practices. When it comes to managing product stewardship, firms often struggle to establish the appropriate organizational approaches and a notable number are still grappling with manual data collection, disparate databases and decentralized offline access of information.
Watch Now

How chemical companies maximize spot, off-spec & expired product sales

Kemgo

Just a days away from the useful innovative ways chemical companies can sell expired, near-spec, off-spec and even spot products in the digital age to maximize revenues and enhance efficiency webinar.
Watch Now

Shining a Nanofocused Light on the Hidden Secrets of Stradivari’s Violins

No one can deny the extraordinary aesthetic and acoustic features of Stradivari’s violins. While their worldwide reputation for quality goes unquestioned
Watch Now

Transitioning Chemical Specialties from Clinical to Commercial in Small Molecule Drug Synthesis

Merck Millipore

In this webinar, we will explore best practice approaches for seamless handover at critical junctures en route to commercial manufacturing of small molecule drugs. One of the biggest challenges in today's small molecule drug development are the different requirements on quality and supply chain going from exploratory research to commercial manufacturing. A key risk to consider is the over- and/or underengineering of chemical specialties for drug synthesis leading to higher total cost of ownership.
Watch Now

Spotlight

resources